- Next generation IR is about linking the essential communities
- A key part of ensuring success is to establish our clients overall corporate profile via a three-pronged approach:
- Establish a substantial presence for the client in the mainstream life sciences investment community (bankers, analysts, crossover funds, etc)
- Ensure the company is engaged with all the relevant players in the business development space
- Strengthen the connectivity between the client and the KOL community
- Rationale for this approach:
- These communities are all linked at the core.
Often, institutional investors via consulting networks speak with KOLs during their diligence process for an investment opportunity. Additionally, pharma's business development professionals and the internal scientists speak with KOLs as a way to screen for interesting technologies to license, partner, etc. By combining these elements, this system offers the ideal platform to provide management teams with the most thorough pipeline of information and ideas to enable strategic decisions and produce meaningful relationships.
